A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

NCT00737464 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: methoxy polyethylene glycol-epoetin beta [Mircera]

Sponsor

Hoffmann-La Roche